首页> 美国卫生研究院文献>other >Kinetic and structural studies of phosphodiesterase-8A and implication on the inhibitor selectivity
【2h】

Kinetic and structural studies of phosphodiesterase-8A and implication on the inhibitor selectivity

机译:磷酸二酯酶8A的动力学和结构研究及其对抑制剂选择性的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cyclic nucleotide phosphodiesterase-8 (PDE8) is a family of cAMP-specific enzymes and plays important roles in many biological processes, including T-cell activation, testosterone production, adrenocortical hyperplasia, and thyroid function. However, no PDE8 selective inhibitors are available for trial treatment of human diseases. Here we report kinetic properties of the highly active PDE8A1 catalytic domain prepared from refolding and its crystal structures in the unliganded and 3-isobutyl-1-methylxanthine (IBMX) bound forms at 1.9 and 2.1 Å resolutions, respectively. The PDE8A1 catalytic domain has KM of 1.8 μM, Vmax of 6.1 μmol/min/mg, kcat of 4.0 s−1 for cAMP, and KM of 1.6 mM, Vmax of 2.5 μmol/min/mg, kcat of 1.6 s−1 for cGMP, thus indicating that the substrate specificity of PDE8 is dominated by KM. The structure of the PDE8A1 catalytic domain has similar topology as those of other PDE families, but contains two extra helices around Asn685-Thr710. Since this fragment is distant from the active site of the enzyme, its impact on the catalysis is unclear. The PDE8A1 catalytic domain is insensitive to the IBMX inhibition (IC50 = 700 μM). The unfavorable interaction of IBMX in the PDE8A1-IBMX structure suggests an important role of Tyr748 in the inhibitor binding. Indeed, the mutation of Tyr748 to phenylalanine increases the PDE8A1 sensitivity to several non-selective or family-selective PDE inhibitors. Thus, the structural and mutagenesis studies provide not only insight into the enzymatic properties, but also guidelines for design of PDE8 selective inhibitors.
机译:环核苷酸磷酸二酯酶-8(PDE8)是cAMP特异的酶家族,在许多生物过程中起重要作用,包括T细胞活化,睾丸激素生成,肾上腺皮质增生和甲状腺功能。但是,没有PDE8选择性抑制剂可用于人类疾病的试验治疗。在这里,我们报告了由重折叠制备的高活性PDE8A1催化结构域的动力学性质及其晶体结构,分别为1.9和2.1Å分辨率的未配体和3-异丁基-1-甲基黄嘌呤(IBMX)结合形式。 PDE8A1催化域的KM为1.8μM,Vmax为6.1μmol/ min / mg,cAMP的kcat为4.0 s -1 ,KM为1.6 mM,Vmax为2.5μmol/ min / mg, cGMP的kcat为1.6 s -1 ,因此表明PDE8的底物特异性由KM决定。 PDE8A1催化域的结构具有与其他PDE家族相似的拓扑,但在Asn685-Thr710周围包含两个额外的螺旋。由于该片段远离酶的活性位点,因此不清楚其对催化的影响。 PDE8A1催化域对IBMX抑制不敏感(IC50 = 700μM)。 IBMX在PDE8A1-IBMX结构中的不利相互作用表明Tyr748在抑制剂结合中的重要作用。实际上,Tyr748突变为苯丙氨酸会增加PDE8A1对几种非选择性或家族选择性PDE抑制剂的敏感性。因此,结构和诱变研究不仅提供了对酶学性质的深入了解,而且为设计PDE8选择性抑制剂提供了指导。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号